Keyword Search Year None 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Oct 23, 2026 Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 Read more » Oct 23, 2026 Labcorp Announces Definitive Agreement to Acquire Millennium Health Read more » Oct 22, 2026 Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential Read more » Oct 21, 2026 Labcorp Declares Quarterly Dividend Read more » Oct 20, 2026 Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp Read more » Oct 15, 2026 Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health Read more » Oct 13, 2026 Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test Read more » Sep 30, 2026 Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026 Read more » Sep 10, 2026 Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day Read more » Sep 08, 2026 Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials Read more » Aug 31, 2026 Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Read more » Aug 28, 2026 Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference Read more » Aug 24, 2026 Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings Read more » Aug 18, 2026 Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health Read more » Aug 17, 2026 Labcorp to Host Investor Day on September 10, 2026 Read more » Aug 10, 2026 Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma Read more » Aug 04, 2026 Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer Read more » Jul 30, 2026 Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance Read more » Jul 27, 2026 Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing Read more » Jul 09, 2026 Labcorp Declares Quarterly Dividend Read more » Jun 30, 2026 Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 Read more » Jun 22, 2026 Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test Read more » May 29, 2026 Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer Read more » May 28, 2026 Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects Read more » May 27, 2026 Labcorp to Present at the Jefferies Global Healthcare Conference Read more » Current page 1 Page 2 Next page next › Last page last »
